Morgan Stanley’s Ocugen OCGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $575K | Sell |
375,656
-302,250
| -45% | -$459K | ﹤0.01% | 5481 |
|
|
2026
Q1 | $1.23M | Buy |
677,906
+214,452
| +46% | +$371K | ﹤0.01% | 5037 |
|
|
2025
Q4 | $626K | Buy |
463,454
+172,890
| +60% | +$246K | ﹤0.01% | 5401 |
|
|
2025
Q3 | $474K | Sell |
290,564
-321,134
| -52% | -$356K | ﹤0.01% | 5514 |
|
|
2025
Q2 | $594K | Sell |
611,698
-231,699
| -27% | -$192K | ﹤0.01% | 5386 |
|
|
2025
Q1 | $596K | Sell |
843,397
-101,224
| -11% | -$70K | ﹤0.01% | 5257 |
|
|
2024
Q4 | $760K | Sell |
944,621
-16,806
| -2% | -$15.4K | ﹤0.01% | 5224 |
|
|
2024
Q3 | $954K | Buy |
961,427
+333,768
| +53% | +$458K | ﹤0.01% | 5068 |
|
|
2024
Q2 | $973K | Buy |
627,659
+8,254
| +1% | +$12.9K | ﹤0.01% | 4974 |
|
|
2024
Q1 | $1.02M | Buy |
619,405
+323,236
| +109% | +$271K | ﹤0.01% | 4943 |
|
|
2023
Q4 | $170K | Buy |
296,169
+15,348
| +5% | +$6.15K | ﹤0.01% | 5753 |
|
|
2023
Q3 | $112K | Sell |
280,821
-68,793
| -20% | -$34K | ﹤0.01% | 5841 |
|
|
2023
Q2 | $190K | Sell |
349,614
-48,166
| -12% | -$30.9K | ﹤0.01% | 5668 |
|
|
2023
Q1 | $339K | Sell |
397,780
-48,917
| -11% | -$53.3K | ﹤0.01% | 5464 |
|
|
2022
Q4 | $581K | Buy |
446,697
+23,413
| +6% | +$36.5K | ﹤0.01% | 5167 |
|
|
2022
Q3 | $753K | Sell |
423,284
-2,092,933
| -83% | -$5.21M | ﹤0.01% | 5054 |
|
|
2022
Q2 | $5.71M | Buy |
2,516,217
+496,040
| +25% | +$1.19M | ﹤0.01% | 3637 |
|
|
2022
Q1 | $6.67M | Buy |
2,020,177
+1,414,556
| +234% | +$4.97M | ﹤0.01% | 3369 |
|
|
2021
Q4 | $2.76M | Sell |
605,621
-34,462
| -5% | -$260K | ﹤0.01% | 4310 |
|
|
2021
Q3 | $4.6M | Buy |
640,083
+51,013
| +9% | +$374K | ﹤0.01% | 3813 |
|
|
2021
Q2 | $4.73M | Buy |
589,070
+565,275
| +2,376% | +$4.77M | ﹤0.01% | 3836 |
|
|
2021
Q1 | $162K | Sell |
23,795
-40,992
| -63% | -$273K | ﹤0.01% | 5773 |
|
|
2020
Q4 | $118K | Buy |
64,787
+48,832
| +306% | +$23.5K | ﹤0.01% | 5845 |
|
|
2020
Q3 | $5K | Buy |
15,955
+1,196
| +8% | +$458 | ﹤0.01% | 6445 |
|
|
2020
Q2 | $3K | Buy |
+14,759
| New | +$4.44K | ﹤0.01% | 6398 |
|
|
2019
Q2 | – | Sell |
-23
| Closed | – | – | 6707 |
|
|
2019
Q1 | $0 | Hold |
23
| – | – | ﹤0.01% | 6668 |
|
|
2018
Q4 | $0 | Sell |
23
-310
| -93% | -$9.88K | ﹤0.01% | 6680 |
|
|
2018
Q3 | $11K | Hold |
333
| – | – | ﹤0.01% | 6286 |
|
|
2018
Q2 | $50K | Hold |
333
| – | – | ﹤0.01% | 5918 |
|
|
2018
Q1 | $55K | Buy |
+333
| New | +$53.1K | ﹤0.01% | 5863 |
|
|
2016
Q2 | – | Sell |
-10
| Closed | -$1K | – | 6604 |
|
|
2016
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 6476 |
|
|
2015
Q4 | $2K | Sell |
10
-63
| -86% | -$14.1K | ﹤0.01% | 6509 |
|
|
2015
Q3 | $17K | Buy |
73
+44
| +152% | +$15.9K | ﹤0.01% | 6098 |
|
|
2015
Q2 | $11K | Sell |
29
-4
| -12% | -$1.93K | ﹤0.01% | 6278 |
|
|
2015
Q1 | $19K | Sell |
33
-16
| -33% | -$9.22K | ﹤0.01% | 6066 |
|
|
2014
Q4 | $32K | Buy |
+49
| New | +$32.3K | ﹤0.01% | 5942 |
|
Other funds holding OCGN
RI
IC
GC
Morgan Stanley's OCGN Position: Q2 2026 in Review
Morgan Stanley reduced its Ocugen (OCGN) stake by 45% in Q2 2026, selling an estimated $459K and leaving 375,656 shares worth $575K. The position accounts for ﹤0.01% of the portfolio, ranked #5481.
Morgan Stanley first reported a position in OCGN in Q4 2014 and has held it in 36 quarters since. The position peaked at $6.67M in Q1 2022. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.
- Morgan Stanley held 375,656 shares of Ocugen worth $575K as of Q2 2026.
- Morgan Stanley sold 302,250 Ocugen shares in Q2 2026, an estimated $459K.
- Ocugen made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5481 holding.
- Morgan Stanley first reported a position in Ocugen in Q4 2014 and has held it in 36 quarters since.
- Morgan Stanley's Ocugen position peaked at $6.67M in Q1 2022.
- 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.